FDA Warns of Diabetes Rx Risk
The US Food and Drug Administration (FDA) has issued a safety announcement about the type 2 diabetes medication pioglitazone.
Breast Cancer Survival: Going Up
In many parts of the world, breast cancer may not be quite as deadly as it used to be, according to a new study.
The Case for Age Restrictions on Tanning
Placing age restrictions on tanning bed use could save thousands of lives, according to a new study.
Cancer Diagnosis Age and Your Heart
If you're diagnosed with cancer, your age when you get that diagnosis could help determine your risk of deadly heart disease, according to a new study.
A New Job for Opdivo
The US Food and Drug Administration (FDA) has expanded the use of Opdivo (nivolumab).
In Breast Reconstruction, Age May Not Matter
When measuring outcomes in breast reconstruction after a mastectomy, age may be just a number, a new study found.
How Precision Medicine Helped Breast Cancer Treatment
Advances in precision medicine have improved breast cancer treatment, according to a new study.
A New Rx for Cancer of the Soft Tissues
The US Food and Drug Administration (FDA) has approved Lartruvo (olaratumab) to treat soft tissue sarcoma (STS).
Tecentriq Gets a New Job
The US Food and Drug Administration has approved Tecentriq (atezolizumab) to treat advanced lung cancer.
A Possible Risk of Androgen Deprivation Therapy
Men with prostate cancer who take androgen-lowering medication may have a raised risk of dementia, a new study found.